Therefore, the aim of this study was to determine the roles of abnormal esophageal acid exposure and ineffective esophageal motility on the presence of typical and atypical GERD symptoms in ...

This study clearly demonstrates the limitation of symptom index in patients with NCCP. The distribution of esophageal motility disorders in patients presenting with non-GERD-related NCCP has been ...

New research is exploring low-cost, non-invasive ways to diagnose Barrett's esophagus, a condition associated with deadly esophageal cancer, to find effective strategies to identify patients with this ...

New research is exploring low-cost, non-invasive ways to diagnose Barrett's esophagus, a condition associated with deadly ...

There is no reliable treatment for ineffective esophageal motility (IEM), a disorder caused by failed smooth-muscle contraction that is common in patients with gastroesophageal reflux disease.

Write it Out Audio (7:38) Get rid of worries before the exam - A guided practice that clears out worries from the mind; research shows it has increased test performance by at least 5 points. Walk Off ...

One study found that, in the US ... capsule pH testing, esophageal manometry and/or gastric scintigraphy, might help us to identify many patients who have nonreflux disease.

This particular screening, called the Esoguard, is a DNA test for detection of esophageal precancer. The test assesses genes from cells collected non-invasively from the esophagus, using a test ...

This test records the acid levels in the throat to look for problems with reflux. Esophageal manometry: This test determines ...

or esophageal cancer within five years. The study showed that the addition of clinicopathologic factors did not improve the predictive performance of the TissueCypher test; in fact, TissueCypher ...

The T-DOC ® Air-Charged™ ARM Catheter is designed with directional sensors and advanced membrane technology that communicate motility readings ... with more consistent study tracings.

The company said its blood test Promarker Eso showed 94% accuracy in detecting esophageal adenocarcinoma (AEC) in a 165-sample clinical validation study. The trial involved the test detected tell ...